Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Danny Wright

17PUBLICATIONS
107CO-AUTHORS
Respiratory diseasesAutonomic nervous systemAgricultural molecular engineering of nucleic acids and proteinsPredictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

Sort by Publication Date:
|Jun 26, 2024
Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.

Amy Flaxman, Sarah Sebastian, Sofia Appelberg

|May 06, 2024
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.

Mainga Hamaluba, Samuel Sang, Benedict Orindi

|Nov 27, 2021
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations.

Adam Berg, Daniel Wright, Pawan Dulal

|Jul 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models.

Teresa Lambe, Alexandra J Spencer, Kelly M Thomas

|Jun 26, 2021
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.

Ifedayo M O Adetifa, Sophie Uyoga, John N Gitonga

|May 22, 2021
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer

Pageof 3

Frequent Collaborators

12 joint publications

Teresa Lambe

9 joint publications

Sarah Gilbert

7 joint publications

Hannah Sharpe

5 joint publications

Andrew Pollard

4 joint publications

Elizabeth R Allen

4 joint publications

Nick J Edwards

4 joint publications

Alexandra Spencer

4 joint publications

Jordan R Barrett

4 joint publications

Katie J Ewer

4 joint publications

George Warimwe

Frequent Collaborators

12 joint publications

Teresa Lambe

9 joint publications

Sarah Gilbert

7 joint publications

Hannah Sharpe

5 joint publications

Andrew Pollard

Top Related Videos

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on : Aug 21, 2019

7.5K
Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.7K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

10.5K
See more related videos

Top Related Videos

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on : Aug 21, 2019

7.5K
Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.7K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

10.5K
See more related videos